Related Experiment Video
Updated: Dec 21, 2025

04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
20.7K
Which patients are SaPHe in sarcoidosis-associated pulmonary hypertension?
Daniel Vis1,2, Athénaïs Boucly3,4,5, Marc Humbert3,4,5
1Dept of Medicine, Division of Respirology, University of Calgary, Calgary, AB, Canada.
The European Respiratory Journal
|May 16, 2020
Abstract
No abstract available in PubMed .
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
489
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
489
Cardiomyopathy III: Hypertrophic Cardiomyopathy
277
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
277

